China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-05-29 15:29 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Asia, China, Drugs, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer
--------------------------------------------------------------------